成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Shanghai Aladdin Biochemical Technology Co.,Ltd.

Firmenname:Shanghai Aladdin Biochemical Technology Co.,Ltd.
Telefon:400-6206333
E-Mail:market@aladdin-e.com
Nationalit?t:China
URL: www.aladdin-e.com/
Produkte insgesamt:48461
459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485

Produktkatalog

Telazorlimab (anti-TNFRSF4)2126777-87-3
Dysprosium(III) trifluoromethanesulfonate139177-62-1C3DyF9O9S3
Bis(hexamethylene)triamine7-Azatridecan-1,13-diamin143-23-7C12H29N3
Dehydroepiandrosterone sulfate651-48-9C19H28O5S
Xentuzumab (anti-IGF1)1417158-65-6
Bimagrumab (anti-ACVR2B)1356922-05-8
Meropenem-d61133424-00-6C17H25N3O5S
Imazapic104098-48-8C14H17N3O3
IDO-IN-132291164-02-6C26H17F3N4O
Ethyl 2-oxo-4-phenylbutyrateEthyl-2-oxo-4-phenylbutyrat64920-29-2C12H14O3
Ranibizumab (anti-VEGFA)347396-82-1C11H12N2O2
Nadecnemab (anti-GFRA3)2377679-19-9
Benzyldiphenylphosphine7650-91-1C19H17P
Codrituzumab (anti-GPC3)1365267-33-9
Urelumab (anti-TNFRSF9)934823-49-1
Elotuzumab (anti-SLAMF7)915296-00-3
Quetmolimab (anti-CX3CL1)2084037-83-0
Bexmarilimab (anti-STAB1)2259301-27-2
Narsoplimab (anti-MASP2)2108782-45-0
8-Azahypoxanthine4,5-Dihydro-1H-triazolo[4,5-d]pyrimidin-4-ol2683-90-1C4H3N5O
Sirtratumab (anti-SLITRK6)1824663-82-2
Rosmantuzumab (anti-RSPO3)1684393-04-1
Bivatuzumab (anti-CD44v6)214559-60-1
Apelin 17 TFA217082-57-0C96H156N34O20S
Tamrintamab (anti-DPEP3)2148325-59-9
Cinpanemab (anti-Alpha-synuclein)2094516-02-4
Mogamulizumab (anti-CCR4)1159266-37-1
Alizarin Yellow R sodium saltNatrium-5-[(4-nitrophenyl)azo]salicylat1718-34-9C13H8N3NaO5
2-(azetidin-1-yl)ethan-1-amine795299-77-3C5H12N2
Tesnatilimab (anti-NKG2D)2242758-08-1
Lacnotuzumab (anti-M-CSF)1831128-32-5
Tesidolumab (anti-Complement C5)1531594-08-7
Sonepcizumab (anti-Sphingosine-1-phosphate)1031360-18-5
Galiximab (anti-CD80)357613-77-5
Idactamab (anti-SLC1A5)2245205-37-0
Apamistamab (anti-PTPRC)2097132-02-8
Ravulizumab (anti-Complement C5)1803171-55-2
Itolizumab (anti-CD6)1116433-11-4
Lumiliximab (anti-FceR2)357613-86-6
Vopratelimab (anti-ICOS)2039148-04-2
KWAR23 (anti-SIRPg)2243227-60-1
Narnatumab (anti-RON)1188275-92-4
Tisotumab (anti-F3)1418628-81-5
Zagotenemab (anti-Tau)2019133-28-7
Vandortuzumab (anti-STEAP1)1557989-52-2
Ladiratuzumab (anti-SLC39A6)1629760-28-6
Concizumab (anti-TFPI)1312299-39-0
Serplulimab (anti-PDCD1)2231029-82-4
Lexatumumab (anti-TNFRSF10B)845816-02-6
Vunakizumab (anti-IL-17a)1792181-33-9
Indusatumab (anti-GUCY2C)1497400-26-6
Ulocuplumab (anti-CXCR4)1375830-34-4
Vantictumab (anti-FZD)1345009-45-1
Fulranumab (anti-NGF)902141-80-4
Ianalumab (anti-TNFRSF13C)1929549-92-7
Gevokizumab (anti-IL-1b)1129435-60-4
Pascolizumab (anti-IL-4)331243-22-2
Gemtuzumab (anti-CD33)220578-59-6
Seribantumab (anti-ERBB3)1334296-12-6
Tarextumab (anti-NOTCH3)1359940-55-8
Zansecimab (anti-ANGPT2)2415205-37-5
Vorsetuzumab (anti-CD70)1165740-62-4
Lemzoparlimab (anti-CD47)2377483-71-9
Flanvotumab (anti-TYRP1)1188277-05-5
Guselkumab (anti-IL-23)1350289-85-8
Ixekizumab (anti-CTLA-8)1143503-69-8
Oxelumab (anti-TNFSF4)1186098-83-8
Sirukumab (anti-IL-6)1194585-53-9
Ragifilimab (anti-TNFRSF18)2207590-51-8
Depatuxizumab mafodotin (anti-EGFR)1585973-65-4
Belimumab (anti-TNFSF13B)356547-88-1
Dostarlimab (anti-PD-1)2022215-59-2
Daclizumab (anti-IL2RA)152923-56-3
Tinurilimab (anti-CEACAM6)2226224-30-0
Otilimab (anti-GM-CSF)1638332-55-4
Eculizumab (anti-Complement C5)219685-50-4
Abelacimab(anti-Factor XI)2098724-83-3
Enoblituzumab (anti-CD276)1353485-38-7
Bermekimab (anti-IL-1a)1401965-15-8
Inebilizumab (anti-CD19)1299440-37-1
Prezalumab (anti-B7-H2)1523164-68-2
Ocrelizumab (anti-CD20)637334-45-3C19H16N2O5
Enokizumab (anti-IL-9)909875-08-7
Emibetuzumab (anti-MET)1365287-97-3
Eldelumab (anti-CXCL10)946414-98-8
Rilotumumab (anti-HGF)872514-65-3
Carotuximab (anti-CD105)1268714-50-6
Brazikumab (anti-IL-23)1610353-18-8
Ontamalimab (anti-MADCAM1)2098790-40-8
Avdoralimab (anti-C5AR1)2226393-85-5
Datopotamab (anti-TROP2)2267989-53-5
Denintuzumab (anti-CD19)1630074-14-4
Labetuzumab govitecan (anti-CEACAM5)1469876-18-3
Efalizumab (anti-ITGAL)214745-43-4
Enfortumab (anti-NECTIN4)1448664-46-7
Dinutuximab (anti-GD2)1363687-32-4
Daxdilimab (anti-ILT7)2245966-28-1
Ponsegromab (anti-GDF15)2368950-15-4
Girentuximab (anti-CA9)916138-87-9
Imaprelimab (anti-CD146)2014343-04-3
459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485
Copyright 2019 ? ChemicalBook. All rights reserved